For construction of the plasmid pET21a-CueR, the E. coli CueR gene was PCR-amplified from E. coli genomic DNA and ligated into pET21a vector with C-terminal 6×His-tag using Nde I and Xho I restriction sites. Mutations in the plasmid were introduced by oligos following the Quickchange-site-directed mutagenesis protocol (Stratagene).
All constructs were transformed into chemically competent E. coli BL21(DE3) cells. The cells were grown in LB medium with 100 μg/mL ampicillin at 37°C to the OD600 value of 0.6, and protein expression was induced with 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) at 20°C for 16 h. The harvested cells were suspended in lysis buffer containing 50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 10 mM imidazole, 5% (v/v) glycerol and lysed via sonication. The lysate was then centrifuged at 80,000 g for 1 h. The recombinant CueR protein was purified through a 5-mL HisTrap column (GE Healthcare) and 5-mL HiTrap Heparin column (GE Healthcare) and further loaded onto a gel filtration column, 120-mL HiLoad 16/600 Superdex 200 in a buffer containing 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM DTT. The final sample was aliquoted, flash-frozen in liquid nitrogen, and stored at −80°C until use.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.